Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
CRH
CRH
|
+$150M |
| 2 |
Kenvue
KVUE
|
+$98.9M |
| 3 |
Textron
TXT
|
+$50.7M |
| 4 |
Extra Space Storage
EXR
|
+$23.3M |
| 5 |
AngloGold Ashanti
AU
|
+$17.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.12B |
| 2 |
Microsoft
MSFT
|
+$890M |
| 3 |
Amazon
AMZN
|
+$463M |
| 4 |
NVIDIA
NVDA
|
+$425M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$316M |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Healthcare | 13.62% |
| 3 | Consumer Discretionary | 11.97% |
| 4 | Industrials | 9.13% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Box
BOX
$4.78B
| $7.71M | 0.01% |
318,400
+4,300
| +1% | +$104K |
|
1027
Lyft
LYFT
$7.6B
| $7.7M | 0.01% |
730,900
+6,900
| +1% | +$72.7K |
|
1028
Arcosa
ACA
$4.81B
| $7.65M | 0.01% |
106,400
+1,000
| +0.9% | +$71.9K |
|
1029
Adient
ADNT
$2B
| $7.64M | 0.01% |
208,198
+500
| +0.2% | +$18.4K |
|
|
IMGN
1030
DELISTED
Immunogen Inc
IMGN
| $7.63M | 0.01% |
480,800
+4,700
| +1% | +$74.6K |
|
1031
Mr. Cooper
COOP
$14.1B
| $7.61M | 0.01% |
142,100
-2,900
| -2% | -$155K |
|
1032
Champion Homes, Inc.
SKY
$4.31B
| $7.6M | 0.01% |
119,300
+1,300
| +1% | +$82.8K |
|
1033
Penske Automotive Group
PAG
$12.2B
| $7.6M | 0.01% |
45,500
+400
| +0.9% | +$66.8K |
|
1034
Insmed
INSM
$30.8B
| $7.57M | 0.01% |
299,900
+2,900
| +1% | +$73.2K |
|
1035
Glaukos
GKOS
$5.02B
| $7.57M | 0.01% |
100,600
+1,600
| +2% | +$120K |
|
1036
10x Genomics
TXG
$1.63B
| $7.57M | 0.01% |
183,400
-6,900
| -4% | -$285K |
|
1037
Kyndryl
KD
$7.57B
| $7.56M | 0.01% |
500,900
+5,600
| +1% | +$84.6K |
|
1038
Janus Henderson
JHG
$7.08B
| $7.52M | 0.01% |
291,305
+2,800
| +1% | +$72.3K |
|
1039
AppFolio
APPF
$10.1B
| $7.51M | 0.01% |
41,100
+600
| +1% | +$110K |
|
1040
Assured Guaranty
AGO
$3.96B
| $7.49M | 0.01% |
123,800
+800
| +0.7% | +$48.4K |
|
1041
First Financial Bankshares
FFIN
$5.13B
| $7.49M | 0.01% |
298,100
+3,000
| +1% | +$75.4K |
|
1042
CRISPR Therapeutics
CRSP
$5.08B
| $7.48M | 0.01% |
164,800
+2,100
| +1% | +$95.3K |
|
1043
Alpha Metallurgical Resources
AMR
$1.86B
| $7.45M | 0.01% |
28,700
-700
| -2% | -$182K |
|
1044
Herc Holdings
HRI
$4.29B
| $7.45M | 0.01% |
62,646
+5,400
| +9% | +$642K |
|
1045
Black Hills Corp
BKH
$4.33B
| $7.44M | 0.01% |
147,079
+2,800
| +2% | +$142K |
|
1046
Leggett & Platt
LEG
$1.34B
| $7.43M | 0.01% |
292,600
+2,900
| +1% | +$73.7K |
|
1047
AMN Healthcare
AMN
$727M
| $7.43M | 0.01% |
87,200
-900
| -1% | -$76.7K |
|
1048
Brink's
BCO
$4.9B
| $7.41M | 0.01% |
102,000
+700
| +0.7% | +$50.8K |
|
|
NARI
1049
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.4M | 0.01% |
113,100
+10,300
| +10% | +$674K |
|
1050
Varonis Systems
VRNS
$6.41B
| $7.37M | 0.01% |
241,254
+6,900
| +3% | +$211K |
|